AAAAAA

   
Results: 1-25 | 26-37
Results: 1-25/37
PROGNOSTIC IMPACT OF AMENORRHEA AFTER ADJUVANT CHEMOTHERAPY IN PREMENOPAUSAL BREAST-CANCER PATIENTS WITH AXILLARY NODE INVOLVEMENT - RESULTS OF THE INTERNATIONAL BREAST-CANCER STUDY-GROUP (IBCSG) TRIAL-VI
Authors: PAGANI O ONEILL A CASTIGLIONE M GELBER RD GOLDHIRSCH A RUDENSTAM CM LINDTNER J COLLINS J CRIVELLARI D COATES A CAVALLI F THURLIMANN B SIMONCINI E FEY M PRICE K SENN HJ
Citation: O. Pagani et al., PROGNOSTIC IMPACT OF AMENORRHEA AFTER ADJUVANT CHEMOTHERAPY IN PREMENOPAUSAL BREAST-CANCER PATIENTS WITH AXILLARY NODE INVOLVEMENT - RESULTS OF THE INTERNATIONAL BREAST-CANCER STUDY-GROUP (IBCSG) TRIAL-VI, European journal of cancer, 34(5), 1998, pp. 632-640
DOSE-RESPONSE EFFECT OF ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL (CMF) IN NODE-POSITIVE BREAST-CANCER
Authors: COLLEONI M PRICE K CASTIGLIONEGERTSCH M GOLDHIRSCH A COATES A LINDTNER J COLLINS J GELBER RD THURLIMANN B RUDENSTAM CM
Citation: M. Colleoni et al., DOSE-RESPONSE EFFECT OF ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL (CMF) IN NODE-POSITIVE BREAST-CANCER, European journal of cancer, 34(11), 1998, pp. 1693-1700
DOSE-FINDING STUDY OF HIGH-DOSE EPIRUBICIN (E) AND DOCETAXEL (D) AS FIRST-LINE CHEMOTHERAPY IN ADVANCED BREAST-CANCER (ABC)
Authors: PAGANI O SESSA C VANDENBULCKE T MARTINELLI G ZAMPINO G NOLE F ZIMATORE M LOCATELLI M CRIVELLARI D BUONADONNA A THURLIMANN B HESS D BORNER M BAUER J RIGGI M RIVA A GOLDHIRSCH A
Citation: O. Pagani et al., DOSE-FINDING STUDY OF HIGH-DOSE EPIRUBICIN (E) AND DOCETAXEL (D) AS FIRST-LINE CHEMOTHERAPY IN ADVANCED BREAST-CANCER (ABC), Annals of oncology, 9, 1998, pp. 74-74
IBCSG - INTERNATIONAL BREAST-CANCER STUDY-GROUP IBCSG TRIAL 11-93 DESIGN - N-CANCER(, ER+ OR PGR+, PREMENOPAUSAL BREAST)
Authors: THURLIMANN B
Citation: B. Thurlimann, IBCSG - INTERNATIONAL BREAST-CANCER STUDY-GROUP IBCSG TRIAL 11-93 DESIGN - N-CANCER(, ER+ OR PGR+, PREMENOPAUSAL BREAST), Onkologie, 21(3), 1998, pp. 266-267
ICON2 - RANDOMIZED TRIAL OF SINGLE-AGENT CARBOPLATIN AGAINST 3-DRUG COMBINATION OF CAP (CYCLOPHOSPHAMIDE, DOXORUBICIN, AND CISPLATIN) IN WOMEN WITH OVARIAN-CANCER
Authors: PARMAR MKB TORRI V BONAVENTURA A BONAZZI C COLOMBO N DELALOYE JF MARSONI S MANGIONI C SANDERCOCK J SESSA C WILLIAMS C TINAZZI A FLANN M GEISER K SCORPIGLIONE N STEWART JF CHAVES J PALMEIRO E CURTAIN A MCCORMACK T GENNATAS C MARRAS F OPPO TG BALESTRINO M MALZONI C MALZONI M BELLI M GEMINIANI ML CRESTANI G MONACO A VAVALA V PIATTO E BARATTINI G FORNARA PG CHETRI MC SANTEUFEMIA G ARTIOLI F CARONE D FANIZZA G TRENTADUE R PRIOLO D SCOLLO P NIGRO SC PETRINA M MASTRANTONIO P SPANNA GD ZAGNI R BELLONI C COLLEONI R REDAELLI L CAVAGNINI A DICOSTANZO G PERRONI D ARIENTI S ORFANOTTI G CANTONI FM SECLI R BIANCHI A MARTINELLO R MOLLICA G MAIZZI D PICCHIARELLI ME FIORINI G BORSANI M COLOMBO E GARSIA S MELGRATI L PAGGI G BRUNENGHI GM CASINI M ISA L ALGERI R PROZIO G BELFIORE G ANGELINI F DAPRILE M MORESCHI M MAURI ML NATALE N SENZANI FM PAVANATO G POGGI G GARUTI G LUERTI M CRUCIANI G PAGANO F BACCOLO M PODDI ER BOCCIOLONE L SABELLI MA MAGGI R RESTELLI C DANTONA A LOCATELLI MC PESSI A RAINA A CHIARI S GABRIELE A PITTELLI MR IACOBELLI P DOGLIOTTI L GORZEGNO G MUSSO P VEGNA G COCO G ALLETTI DG PICCIOTTO F LUCCHESE V EPIS A DIPALUMBO VS DRUDI G RAVAIOLI A ZAMPELLA D MORANDI MG GORGA G ZUCCHELLI C CARIELLO S GALLETTO L SUSSIO M MASSACESI L MASSACESI M CARLI A TUCCI E TAJANI E CORRADO G BUMMA S DURANDO A MASSOBRIO M SBERVEGLIERI M BIASIO M GUERCIO E JURA R DANESE S WIERDIS T FARNELLI C TARANTINO G GRASSI R REPETTI F ROCCHI B GRAMPA M ERCOLI A GRISO C SIGNORI E ZANINI L PRESTI M KLIMEK M URBANSKI K BISWAS A VIEGAS O KOCHLI O DREHER E FEY M BECK G LUDIN J BONNEFOI H KRAUER F BAUER J DELMORE G FURRER C LORENZ U THURLIMANN B LORENZ U BRONZ L SANNA P WYSS D GOLDHIRSCH A GYR T LEIDI L PASTORELLI G PAGANI O REY P HAILER U BENZ J KAYE SB REED NS SYMONDS RP ATKINSON RJ AXFORD AT RUSTIN G SECKL MJ GREEN JA SCOTT IV GUTHRIE D HARPER PG CALMAN F DOBBS HJ WEIR P CASSONI A LEDERMAN JA SOUHAMI RL BOZZINO J ADAB F REDMAN CWE SCOBLE JE PATERSON M DANIEL F COWLEY N WILLIAMS CJ SPOONER D HONG A MCILLMURRAY M HENDYIBBS P HALL V IVESON TJ WHITEHOUSE JMA GARRY R LAMONT A ROBINSON A TRASK CW CLUBB AW MURRELL D NEWMAN G WILKINS M GOLDTHORP WO ROBERTS JK RADSTONE DJ WHIPP MJ LEDERMANN JA PATER J BUYSE M OMURA G
Citation: Mkb. Parmar et al., ICON2 - RANDOMIZED TRIAL OF SINGLE-AGENT CARBOPLATIN AGAINST 3-DRUG COMBINATION OF CAP (CYCLOPHOSPHAMIDE, DOXORUBICIN, AND CISPLATIN) IN WOMEN WITH OVARIAN-CANCER, Lancet, 352(9140), 1998, pp. 1571-1576
POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS
Authors: ABE O ABE R ENOMOTO K KIKUCHI K KOYAMA H NOMURA Y SAKAI K SUGIMACHI K TOMINAGA T UCHINO J YOSHIDA M BENRAADT J VANDEVELDE AO VANDONGEN JA VERMORKEN JB GIOKAS G LISSAIOS B HARVEY VJ HOLDAWAY TM KAY RG MASON BH COATES A FORBES JF FOCAN C LOBELLE JP GATES GD POWELL J DURAND M MAURIAC L BARTHOLOMEUS S PICCART MJ GELMAN RS HENDERSON IC SHAPIRO CL HANCOCK AK MASOOD MB PARKER D PRICE JJ JACKSON S RAGAZ J DELOZIER T MACELESECH J HAYBITTLE JL BERRY D BROADWATER G CIRRINCIONE C MUSS H NORTON L BAUM M HOUGHTON J RILEY D DENT DM GUDGEON CA HACKING A GORDON NH DAVIS HL ROMESTAING P LEHINGUE Y OWEN JR MEIER P HOWELL A RIBEIRO GC SWINDELL R ALBANO J DEOLIVEIRA CF GERVASIO H GORDILHO J CARSTENSEN B PALSHOF T JOHANSEN H KORZENIOWSKI S SKOLYSZEWSKI J PORTNOJ SM ANDERSEN KW AXELSSON CK BLICHERTTOFT M MOURIDSEN HT OVERGAARD M ROSE C CORCORAN N TRAMPISCH HJ COMIS RL DAVIDSON NE GRAY R ROBERT N TORMEY DC WOOD W CHETTY U FORREST P JACK W ROSSBACH J SYLVESTER RJ VANDEVELDE CJH CUNNINGHAM MP BONNETERRE J FUMOLEAU P NAMER M BASTERT G RAUSCHECKER H SAUER R SAUERBREI W SCHAUER A SCHUMACHER M DESCHRYVER A BELFIGLIO M MARI E NICOLUCCI A SCORPIGLIONE N YOSEF HMA MCARDLE CS SMITH DC LARA PC BOCCARDO F RUBAGOTTI A ERAZO A MEDINA JY IZUO M MORISHITA Y BENTLEY A DORAN Z FENTIMAN IS HAYWARD JL RUBENS RD KAUFMANN M JONAT W SCHEURLEN H VONFOURNIER D FOUNTZILAS G KLAFSTROM P BLOMQVIST C CUZICK J MARGREITER R CASTIGLIONE M CAVILLI F COLLINS J FORBES J GELBER RD GOLDHIRSCH A LINDTNER J PRICE KN RUDENSTAM CM SENN HJ BLISS JM CHILVERS CED COOMBES RC MARTY M BOROVIK R BRUFMAN G HAYAT H ROBINSON E WIGLER N PANNUTI F TAKASHIMA S YASUTOMI T SONOO H YAMASHITA J OGAWA M WELVAART K HUPPERETS PSGJ BONTE J TENGRUP I TENNVALLNITTBY L MARTIN P ROMAIN S INGLE JN SUMAN VJ BUZDAR AU SMITH T HAKES T WITTES R DELAHUERTA R SAINZ MG BONADONNA G DELVECCHIO M VALAGUSSA P VERONESI U DUBOIS JB BIANCO AR LIPPMAN ME PIERCE LJ SIMON R STEINBERG SM MYLES JD PATER JL PRITCHARD KI ANDERSON S BROWN A BRYANT J COSTANTINO J DIGNAM J FISHER B REDMOND C WIEAND S WOLMARK N JACKSON IM PALMER MK BENGTSSON NO LARSSON LG LYTHGOE JP KISSIN M HANNISDAL E VARHAUG JE NISSENMEYER R BLAMEY RW MITCHELL AK ROBERTSON JFR UEO H MATHE G MISSET JL ABUZAHRA HT CLARKE EA MCLAUGHLIN JR CLARK RM LEVINE M MORIMOTO K SAWA K TAKATSUKA Y GUNDERSEN S HAUERJENSEN M HOST H CROSSLEY E HARRIS A BEIGHTON A CLARKE M COLLINS R DAVIES C EVANS V GODWIN J GREAVES E HARWOOD C JACKSON D JAMES S LAU E MEAD G NAUGHTEN A PETO R TOOTH A RAMBERT P ASSELAIN B SALMON RJ VILCOQ JR ARRIAGADA R HILL C LAPLANCHE A LE MG SPIELMANN M COCCONI G DIBLASIO B CATALANO R CREECH RH BROCKSCHMIDT J COOPER MR ANDRYSEK O BARKMANOVA J FALKSON CI ABRAHAM M KLIJN JGM TREURNIETDONKER AD VANPUTTEN WLJ EASTON D POWLES TJ GAZET JC SEMIGLAZOV V DESHPANDE N DIMARTINO L DOUGLAS P LINDTNER A NOTTER G BRYANT AJS EWING GH KRUSHENKOSLOSKI JL GEORGE WD GOULD A STEWART HJ STRONER P MOLLER TR RYDEN S CARSTENSEN J HATSCHEK T SODERBERG M CARPENTER JT ALBAIN K CROWLEY J GREEN S MARTINO S OSBORNE CK RAVDIN PM RUTQVIST LE WALLGREN A HOLM LE THURLIMANN B BRENNER H HERCBERGS A YOSHIMOTO M DEBOER G PATERSON AHG MEAKIN JW PANZARELLA T NAJA A BAHI J REID M SPITTLE M SENANAYAKE F BERGH J HOLMBERG L SEVELDA P ZIELINSKY CC GNANT M JAKESZ R BUCHANAN RB CROSS M DUNN JA GILLESPIE WM KELLY K MORRISON JM LITTON A CHLEBOWSKI RT BEZWODA WR CAFFIER H
Citation: O. Abe et al., POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS, Lancet, 352(9132), 1998, pp. 930-942
HORMONAL TREATMENT OF BREAST-CANCER - NEW DEVELOPMENTS
Authors: THURLIMANN B
Citation: B. Thurlimann, HORMONAL TREATMENT OF BREAST-CANCER - NEW DEVELOPMENTS, Oncology, 55(6), 1998, pp. 501-507
FACTORS AFFECTING BASE-LINE QUALITY-OF-LIFE IN 2 INTERNATIONAL ADJUVANT BREAST-CANCER TRIALS
Authors: BERNHARD J HURNY C COATES AS PETERSON HF CASTIGLIONEGERTSCH M GELBER RD GALLIGIONI E MARINI G THURLIMANN B FORBES JF GOLDHIRSCH A SENN HJ RUDENSTAM CM
Citation: J. Bernhard et al., FACTORS AFFECTING BASE-LINE QUALITY-OF-LIFE IN 2 INTERNATIONAL ADJUVANT BREAST-CANCER TRIALS, British Journal of Cancer, 78(5), 1998, pp. 686-693
SUBJECTIVE HEALTH ESTIMATIONS (SHE) IN PATIENTS WITH ADVANCED BREAST-CANCER - AN ADAPTED UTILITY CONCEPT FOR CLINICAL-TRIALS
Authors: HURNY C VANWEGBERG B BACCHI M BERNHARD J THURLIMANN B REAL O PEREY L BONNEFOI H COATES A
Citation: C. Hurny et al., SUBJECTIVE HEALTH ESTIMATIONS (SHE) IN PATIENTS WITH ADVANCED BREAST-CANCER - AN ADAPTED UTILITY CONCEPT FOR CLINICAL-TRIALS, British Journal of Cancer, 77(6), 1998, pp. 985-991
EXEMESTANE EXPERIENCE IN BREAST-CANCER-TREATMENT
Authors: LONNING PE PARIDAENS R THURLIMANN B PISCITELLI G DISALLE E
Citation: Pe. Lonning et al., EXEMESTANE EXPERIENCE IN BREAST-CANCER-TREATMENT, Journal of steroid biochemistry and molecular biology, 61(3-6), 1997, pp. 151-155
DOSE-FINDING STUDY OF HIGH-DOSE EPIRUBICIN (E) AND DOCETAXEL (T) AS FIRST LINE CHEMOTHERAPY IN ADVANCED BREAST-CANCER (ABC)
Authors: PAGANI O AAPRO M MARTINELLI G BAUER J BORNER M CRIVELLARI D THURLIMANN B VANDENBULCKE T GOLDHIRSCH A
Citation: O. Pagani et al., DOSE-FINDING STUDY OF HIGH-DOSE EPIRUBICIN (E) AND DOCETAXEL (T) AS FIRST LINE CHEMOTHERAPY IN ADVANCED BREAST-CANCER (ABC), European journal of cancer, 33, 1997, pp. 654-654
FORMESTANE VERSUS MEGESTROL-ACETATE IN POSTMENOPAUSAL BREAST-CANCER PATIENTS AFTER FAILURE OF TAMOXIFEN - A PHASE-III PROSPECTIVE RANDOMIZED CROSS-OVER TRIAL OF 2ND-LINE HORMONAL TREATMENT (SAKK-20 90)/
Authors: THURLIMANN B CASTIGLIONE M HSUSCHMITZ SF CAVALLI F BONNEFOI H FEY MF MORANT R LOHNERT T GOLDHIRSCH A
Citation: B. Thurlimann et al., FORMESTANE VERSUS MEGESTROL-ACETATE IN POSTMENOPAUSAL BREAST-CANCER PATIENTS AFTER FAILURE OF TAMOXIFEN - A PHASE-III PROSPECTIVE RANDOMIZED CROSS-OVER TRIAL OF 2ND-LINE HORMONAL TREATMENT (SAKK-20 90)/, European journal of cancer, 33(7), 1997, pp. 1017-1024
3RD-LINE HORMONAL TREATMENT WITH EXEMESTANE IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER PROGRESSING ON AMINOGLUTETHIMIDE - A PHASE-II MULTICENTER MULTINATIONAL STUDY
Authors: THURLIMANN B PARIDAENS R SERIN D BONNETERRE J ROCHE H MURRAY R DISALLE E LANZALONE S ZURLO MG PISCITELLI G
Citation: B. Thurlimann et al., 3RD-LINE HORMONAL TREATMENT WITH EXEMESTANE IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER PROGRESSING ON AMINOGLUTETHIMIDE - A PHASE-II MULTICENTER MULTINATIONAL STUDY, European journal of cancer, 33(11), 1997, pp. 1767-1773
MENSTRUAL-CYCLE AND TIMING OF BREAST SURGERY IN PREMENOPAUSAL NODE-POSITIVE BREAST-CANCER - RESULTS OF THE INTERNATIONAL BREAST-CANCER STUDY-GROUP (IBCSG) TRIAL-VI
Authors: GOLDHIRSCH A GELBER RD CASTIGLIONE M ONEILL A THURLIMANN B RUDENSTAM CM LINDTNER J COLLINS J FORBES J CRIVELLARI D COATES A CAVALLI F SIMONCINI E FEY MF PAGANI O PRICE K SENN HJ
Citation: A. Goldhirsch et al., MENSTRUAL-CYCLE AND TIMING OF BREAST SURGERY IN PREMENOPAUSAL NODE-POSITIVE BREAST-CANCER - RESULTS OF THE INTERNATIONAL BREAST-CANCER STUDY-GROUP (IBCSG) TRIAL-VI, Annals of oncology, 8(8), 1997, pp. 751-756
EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY IN COMBINATION WITH TAMOXIFEN FOR NODE-POSITIVE POSTMENOPAUSAL BREAST-CANCER PATIENTS
Authors: CASTIGLIONEGERTSCH M GOLDHIRSCH A GUSTERSON B BETTELHEIM R REED R GUSSET H GEISER K HURNY C BERNHARD J HANGARTNER A MAIBACH R PEDOWSKI R GELBER R PRICE K PETERSON H ZELEN M ISLEY M HINKLE R KAY RG HOLDAWAY IM HARVEY VJ JAGUSCH MF NEAVE L MASON BM EVANS B BENJAMIN CS CARTER JF GILLMAN JC MACK D BENSONCOOPER D MONFARDINI S GALLIGIONI E CRIVELLARI D BUONADONNA A MASSARUT S ROSSI C CANDIANI E CARBONE A VOLPE R TROVO MG RONCADIN M SANTINI GF VILLALTA D CORAN F MORASSUT S MARINI G SIMONCINI E MARPICATI P ZANIBONI A SARTORI U BARNI A CERUTTI L ALGHISI A RAFFAGLIO E GARATTINI MP ALBERTINI A GRIGOLATO F MORASSI L BERGONZINI R LAURIOLA C GUDGEON A DENT DM TILTMAN A HACKING A DOWDLE E STEYNOR P TOOP J SCHNURCH HG MOSNY D BENDER HG BOJAR H VERONESI A FOLADORE S PAMICH G BIANCHI G TORRETTA A RUDENSTAM CM WALLGREN A PERSSON S MATTSSON J CAHLIN E HAFSTROM LO HOLMBERG S HULTBORN R COLLDAHLJADERSTROM G GUSTAVSSON B CARLSSON G IVARSSON L THOREN O RUUSVIK O NICKLASSON LG DAHLIN S KARLSSON G LINDBERG B SUNDBACK A BERGEGARDH S SALANDER H ANDERSSON C HESSMAN Y NELZEN O HEIDEMAN M RAMHULT T SVENSSON JH LIDBERG P BJORK S LINDTNER J ERZEN D CERAR O STABUC B GOLOUH R LAMOVEC J SEBEK S KRAMBERGER M VRHOVEC I CORTESFUNES H MARTINEZTELLO F MENDIOLA C CRUZVIGO F LARRODERA ML SIERRA A MIRANDA P ALONSO S COLLINS J SNYDER R GREGORY P BURAS WI GREEN M GALE T HENDERSON M HART S NEIL S KITCHEN P LOVELL R MCLENNAN R REED R RUSSELL I SCHWARZ M BASSER R ROBERTSON A GILL P CARTER ML MALYCHA P YEOH E WARD G LEONG ASY LOMMAXSMITH J HOOSFALL D DANGELO R BYRNE M VANHAZEL G DEWAR J BUCK M SHEINER HJ INGRAM D STERRETT G HAHNEL R FORBES JF STEWARD J DARBAR SW BISHOP JM SIMMS B ZIOGAS V TATTERSALL MHN COATES A NIESCHE F WEST R RENWICK S DONOVAN J DUVAL P SIMES RJ NG A GLENN D NORTH RA BEITH J OCONNOR RG RICE M STEVENS G FEY M BARTH A DREHER E ISENSCHMID M SCHNEIDER H BUSER K LUDIN J LUTHI JM ALTERMATT HJ LAISSUE JA MARKWALDER R BURGI H SENN HJ THURLIMANN B JUNGI WF MORANT R OEHLSCHLEGEL C HARDMEIER T LUSCHER K RIES G TOPFER M LORENZ U BENZ D SCHILTKNECHT O SPATI B SCHMID L CAVALLI F SESSA C BRONZ L MARTINELLI G MULLER W LUSCIETI P PASSEGA E PEDRINIS E REY P MARTINOLI S SPINELLI A GALFETTI MA LOMBARDI A PEDRAZZINI A LOSA G VARINI M GINIER M HERRMANN R HARDER JF LAFFER U ALMENDRAL AC EPPENBERGER U TORHORST J SIEGENTHALER P PIGUET D BARRELET V BAUMANN RP JOSS R SAUTER C METZGER U ENGELER V HALLER U KOCHLI O LEYVRAZ S PEREY L ANANI P GOMEZ F MIRIMANOFF RO CHAPUIS G DEGRANDI P REYMOND P ALBERTO P SCHAFER P KRAUER F FORNI M AAPRO M EGELI R MEGEVAND R JACOTDESCOMBES E SCHINDLER A NOSEDA G WEBER W LEHMANN W
Citation: M. Castiglionegertsch et al., EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY IN COMBINATION WITH TAMOXIFEN FOR NODE-POSITIVE POSTMENOPAUSAL BREAST-CANCER PATIENTS, Journal of clinical oncology, 15(4), 1997, pp. 1385-1394
DOSE-RESPONSE STUDY OF IBANDRONATE IN THE TREATMENT OF CANCER-ASSOCIATED HYPERCALCEMIA
Authors: RALSTON SH THIEBAUD D HERRMANN Z STEINHAUER EU THURLIMANN B WALLS J LICHINITSER MR RIZZOLI R HAGBERG H HUSS HJ TUBIANAHULIN M BODY JJ
Citation: Sh. Ralston et al., DOSE-RESPONSE STUDY OF IBANDRONATE IN THE TREATMENT OF CANCER-ASSOCIATED HYPERCALCEMIA, British Journal of Cancer, 75(2), 1997, pp. 295-300
EDITORS PAGE ANNOUNCING CURRENT CONTROVERSIES IN CANCER
Authors: SENN HJ THURLIMANN B
Citation: Hj. Senn et B. Thurlimann, EDITORS PAGE ANNOUNCING CURRENT CONTROVERSIES IN CANCER, European journal of cancer, 32A(9), 1996, pp. 1453-1453
MAMMOGRAPHY FOR AGES 40-49 - DO YOUNGER WOMEN BENEFIT FROM SCREENING
Authors: THURLIMANN B
Citation: B. Thurlimann, MAMMOGRAPHY FOR AGES 40-49 - DO YOUNGER WOMEN BENEFIT FROM SCREENING, European journal of cancer, 32A(4), 1996, pp. 567-568
FIRST-LINE FADROZOLE HCI (CGS-16949A) VERSUS TAMOXIFEN IN POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST-CANCER - PROSPECTIVE RANDOMIZED TRIAL OF THE SWISS-GROUP-FOR-CLINICAL-CANCER-RESEARCH SAKK-20 88/
Authors: THURLIMANN B BERETTA K BACCHI M CASTIGLIONEGERTSCH M GOLDHIRSCH A JUNGI WF CAVALLI F SENN HJ FEY M LOHNERT T
Citation: B. Thurlimann et al., FIRST-LINE FADROZOLE HCI (CGS-16949A) VERSUS TAMOXIFEN IN POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST-CANCER - PROSPECTIVE RANDOMIZED TRIAL OF THE SWISS-GROUP-FOR-CLINICAL-CANCER-RESEARCH SAKK-20 88/, Annals of oncology, 7(5), 1996, pp. 471-479
RANDOMIZED PHASE-II TRIAL COMPARING DIFFERENT DOSES OF THE BISPHOSPHONATE IBANDRONATE IN THE TREATMENT OF HYPERCALCEMIA OF MALIGNANCY
Authors: PECHERSTORFER M HERRMANN Z BODY JJ MANEGOLD C DEGARDIN M CLEMENS MR THURLIMANN B TUBIANAHULIN M STEINHAUER EU VANEIJKEREN M HUSS HJ THIEBAUD D
Citation: M. Pecherstorfer et al., RANDOMIZED PHASE-II TRIAL COMPARING DIFFERENT DOSES OF THE BISPHOSPHONATE IBANDRONATE IN THE TREATMENT OF HYPERCALCEMIA OF MALIGNANCY, Journal of clinical oncology, 14(1), 1996, pp. 268-276
BIOCHEMICAL MARKERS OF BONE REMODELING
Authors: ENGLER H THURLIMANN B RIESEN WF
Citation: H. Engler et al., BIOCHEMICAL MARKERS OF BONE REMODELING, Onkologie, 19(2), 1996, pp. 126-131
THE CHANGING APPROACH TO THE TREATMENT OF EARLY BREAST-CANCER
Authors: THURLIMANN B SENN HJ
Citation: B. Thurlimann et Hj. Senn, THE CHANGING APPROACH TO THE TREATMENT OF EARLY BREAST-CANCER, The New England journal of medicine, 334(21), 1996, pp. 1397-1399
CAUSES AND TREATMENT OF BONE PAIN OF MALIGNANT ORIGIN
Authors: THURLIMANN B DESTOUTZ ND
Citation: B. Thurlimann et Nd. Destoutz, CAUSES AND TREATMENT OF BONE PAIN OF MALIGNANT ORIGIN, Drugs, 51(3), 1996, pp. 383-398
DEXVERAPAMIL TO OVERCOME ANTHRACYCLINE-RESISTANCE IN ADVANCED BREAST-CANCER
Authors: KROGER N LEHNERT M MROSS K GIESEKING F THURLIMANN B SCHULLER J KUPPER H HOSSFELD DK
Citation: N. Kroger et al., DEXVERAPAMIL TO OVERCOME ANTHRACYCLINE-RESISTANCE IN ADVANCED BREAST-CANCER, European journal of cancer, 31A, 1995, pp. 361-361
QUALITY VERSUS QUANTITY OF LIFE IN THE TREATMENT OF PATIENTS WITH ADVANCED SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-III COMPARISON OF WEEKLY CARBOPLATIN AND TENIPOSIDE VERSUS CISPLATIN, ADRIAMYCIN, ETOPOSIDE ALTERNATING WITH CYCLOPHOSPHAMIDE, METHOTREXATE, VINCRISTINE AND LOMUSTINE
Authors: JOSS RA ALBERTO P HURNY C BACCHI M LEYVRAZ S THURLIMANN B CERNY T MARTINELLI G STAHEL R LUDWIG C
Citation: Ra. Joss et al., QUALITY VERSUS QUANTITY OF LIFE IN THE TREATMENT OF PATIENTS WITH ADVANCED SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-III COMPARISON OF WEEKLY CARBOPLATIN AND TENIPOSIDE VERSUS CISPLATIN, ADRIAMYCIN, ETOPOSIDE ALTERNATING WITH CYCLOPHOSPHAMIDE, METHOTREXATE, VINCRISTINE AND LOMUSTINE, Annals of oncology, 6(1), 1995, pp. 41-48
Risultati: 1-25 | 26-37